NFE2L2 and hepatocellular carcinoma: As for human HCC, wide studies using whole-exome sequencing and TCGA-derived data have revealed mutations of either Nrf2 (6 to 9%) [18,19] or Keap1 (8%) [19,20], suggesting that the dysregulation of this pathway may play a relevant role in a subset of human HCCs.